Fields »
ABOUT
HELP
BLOG

126 GENES FOUND

Show / hide columns

XML | RDF | TSV | « prev | Page of 3

Gene

 

 

Gene description

x

 

 

Protein class

x

 

 

 

 

Tissue

Cell

Pathology

 

 

 

 

 

 

Subcellular location

x

 

 

RNA tissue category

x

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 
SLC18A1Solute carrier family 18 (vesicular monoamine transporter), member 1FDA approved drug targets
Predicted membrane proteins
Transporters
Tissue enriched
SLC18A2Solute carrier family 18 (vesicular monoamine transporter), member 2FDA approved drug targets
Predicted membrane proteins
Transporters
Tissue enhanced
SLC22A11Solute carrier family 22 (organic anion/urate transporter), member 11FDA approved drug targets
Plasma proteins
Predicted membrane proteins
Transporters
Group enriched
SLC22A6Solute carrier family 22 (organic anion transporter), member 6FDA approved drug targets
Predicted membrane proteins
Transporters
Tissue enriched
SLC22A8Solute carrier family 22 (organic anion transporter), member 8FDA approved drug targets
Predicted membrane proteins
Transporters
Tissue enriched
SLC25A4Solute carrier family 25 (mitochondrial carrier; adenine nucleotide translocator), member 4Disease related genes
FDA approved drug targets
Predicted membrane proteins
Transporters
MitochondriaTissue enhanced
SLC25A5Solute carrier family 25 (mitochondrial carrier; adenine nucleotide translocator), member 5FDA approved drug targets
Plasma proteins
Predicted membrane proteins
Transporters
MitochondriaExpressed in all
SLC25A6Solute carrier family 25 (mitochondrial carrier; adenine nucleotide translocator), member 6FDA approved drug targets
Plasma proteins
Predicted membrane proteins
Transporters
MitochondriaExpressed in all
SLC52A2Solute carrier family 52 (riboflavin transporter), member 2Disease related genes
FDA approved drug targets
Predicted membrane proteins
Predicted secreted proteins
Transporters
Expressed in all
SLC5A2Solute carrier family 5 (sodium/glucose cotransporter), member 2Disease related genes
FDA approved drug targets
Predicted membrane proteins
Transporters
Tissue enriched
SLC6A1Solute carrier family 6 (neurotransmitter transporter), member 1Disease related genes
FDA approved drug targets
Predicted intracellular proteins
Predicted membrane proteins
Transporters
MitochondriaGroup enriched
SLC6A2Solute carrier family 6 (neurotransmitter transporter), member 2Disease related genes
FDA approved drug targets
Plasma proteins
Predicted intracellular proteins
Predicted membrane proteins
Transporters
Mitochondria
Cytosol		Tissue enhanced
SLC6A3Solute carrier family 6 (neurotransmitter transporter), member 3Disease related genes
FDA approved drug targets
Predicted membrane proteins
Transporters
VesiclesNot detected
SLC6A4Solute carrier family 6 (neurotransmitter transporter), member 4FDA approved drug targets
Predicted membrane proteins
Transporters
Golgi apparatus
Vesicles		Group enriched
SLC6A8Solute carrier family 6 (neurotransmitter transporter), member 8Disease related genes
FDA approved drug targets
Plasma proteins
Predicted intracellular proteins
Predicted membrane proteins
Transporters
Mixed
SLC7A11Solute carrier family 7 (anionic amino acid transporter light chain, xc- system), member 11FDA approved drug targets
Plasma proteins
Predicted membrane proteins
Transporters
VesiclesTissue enhanced
SLC8A1Solute carrier family 8 (sodium/calcium exchanger), member 1FDA approved drug targets
Predicted membrane proteins
Predicted secreted proteins
Transporters
Nucleoplasm
Plasma membrane		Tissue enhanced
SLCO2B1Solute carrier organic anion transporter family, member 2B1FDA approved drug targets
Predicted intracellular proteins
Predicted membrane proteins
Transporters
Expressed in all
SNAP25Synaptosomal-associated protein, 25kDaDisease related genes
FDA approved drug targets
Predicted intracellular proteins
Transporters
Tissue enriched
SPECC1L-ADORA2ASPECC1L-ADORA2A readthrough (NMD candidate)FDA approved drug targets
G-protein coupled receptors
Predicted membrane proteins
Transporters
Tissue enhanced
TRPA1Transient receptor potential cation channel, subfamily A, member 1Disease related genes
FDA approved drug targets
Predicted membrane proteins
Transporters
Voltage-gated ion channels
Tissue enhanced
TRPV1Transient receptor potential cation channel, subfamily V, member 1FDA approved drug targets
Predicted membrane proteins
Transporters
Voltage-gated ion channels
Mixed
TSPOTranslocator protein (18kDa)Cancer-related genes
FDA approved drug targets
Predicted membrane proteins
Transporters
Vesicles
Mitochondria
Cytosol		Expressed in all
UGCGUDP-glucose ceramide glucosyltransferaseEnzymes
FDA approved drug targets
Predicted membrane proteins
Transporters
Expressed in all
VAMP1Vesicle-associated membrane protein 1 (synaptobrevin 1)FDA approved drug targets
Predicted membrane proteins
Transporters
Mixed
VAMP2Vesicle-associated membrane protein 2 (synaptobrevin 2)FDA approved drug targets
Predicted membrane proteins
Transporters
Expressed in all

« prev | Page of 3

Contact

The Project

The Human Protein Atlas

The Human Protein Atlas project is funded
by the Knut & Alice Wallenberg foundation.